Nurse Practitioner in Guymon, OK Accepting Medicare

6 Nurse Practitioner nurses found. Showing 1 - 6

Kimberly Kay Wadley, APRN, FNP-C Nurse Practitioner - Family Medicare: Accepting Medicare Assignments Practice Location: 1309 N East St, Guymon, OK 73942 Phone: 580-338-4638    Fax: 580-338-4642

Julie M Hawks-baugh, APRN, CNP Nurse Practitioner - Family Medicare: Accepting Medicare Assignments Practice Location: 1753 N Roosevelt St, Guymon, OK 73942 Phone: 580-338-7792    Fax: 580-338-7797

Selene Garcia-van Camp, APRN FNP-C Nurse Practitioner - Family Medicare: Accepting Medicare Assignments Practice Location: 3247 Ne Highway 54, Guymon, OK 73942 Phone: 580-338-0072

Mary Kathryn Ruiz, APRN, FNP - C Nurse Practitioner - Family Medicare: Medicare Enrolled Practice Location: 2215 N Highway 64, Guymon, OK 73942 Phone: 580-754-2280

Baolong Do, Nurse Practitioner - Family Medicare: Accepting Medicare Assignments Practice Location: 123 Medical Dr, Guymon, OK 73942 Phone: 580-338-3361    Fax: 580-338-1021

Mrs. Lori Ann Harriman, ARNP Nurse Practitioner - Family Medicare: Accepting Medicare Assignments Practice Location: 1753 N Roosevelt St, Guymon, OK 73942 Phone: 580-338-7792    Fax: 580-338-7797

News Archive

ESC/EACTS releases new Myocardial Revascularisation guidelines

Multivessel and left main disease have been long considered as mainstay indications for coronary artery bypass grafting surgery (CABG). This recommendation, however, has been strongly challenged on several occasions. The release of new Myocardial Revascularisation guidelines by ESC and the European Association of Cardio-Thoracic Surgeons (EACTS) at the ESC Congress on Sunday 29 August is likely to shed new light on what has become a controversial topic.

NanoSmart receives USPTO Notice of Allowance for cancer tumor targeting technology

NanoSmart™ Pharmaceuticals, Inc., a California corporation developing novel biopharmaceuticals, is pleased to report that it has received a Notice of Allowance for a US patent on its proprietary cancer tumor targeting technology.

Nearly half of newly-infected HIV patients experience neurologic issues

A team led by researchers from UCSF and Yale has found that half of people newly infected with HIV experience neurologic issues. These neurologic findings are generally not severe and usually resolve after participants started anti-retroviral therapy.

Ludwig-developed antibody drug for deadly brain cancer may have broader applications

A Ludwig Cancer Research study explains why a particular mutation in the epidermal growth factor receptor, a cell surface protein, results in more aggressive tumors and poorer overall survival of patients diagnosed with the brain cancer glioblastoma multiforme.

Read more Medical News

› Verified 5 days ago